Recruiting now
CREST: CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life
A 12-Week Prospective Cohort Study Evaluating the Efficacy of the Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life in Individuals With Menstrual and Pelvic Health Conditions
- Status
- Recruiting now
- Registry ID
- NCT07679074
- Type
- Observational (no treatment given)
- Conditions
- Premenstrual Syndrome, Premenstrual Dysphoric Disorder, Dysmenorrhea, Endometriosis
- What is tested
- Lutea Transcranial Direct Current Stimulation (tDCS) Device (device); Samphire Guided Care Program (behavioral)
- Sponsor
- Samphire Group, Inc.
- Where
- United States
- Participants
- 50 (planned)
- Start
- 2026-06-01
- Completion
- 2027-03-01
- Last update
- 2026-07-01
About the study
This study evaluates the feasibility and efficacy of the Samphire Guided Care (SGC) program * a 12-week structured digital health program combining clinician-led onboarding, at-home neuromodulation using the Lutea tDCS device, neuromodulation coach support, and app-based symptom tracking - on work productivity, employee wellbeing, and quality of life in individuals experiencing mood and cognitive symptoms associated with menstruation, perimenopause, or menopause.
Summary from ClinicalTrials.gov.